ÂÜÀòÂÒÂ×

Dev Chatterjee is an accomplished professional in the field of biomedical technology and research, serving as Managing Director and Principal at Fannin Innovation Studio since October 2013, where the focus is on biomedical technology commercialization. As Chief Scientific Officer and Co-Founder of BreviTest Technologies, LLC, Dev is involved in developing point-of-care diagnostic technologies. Dev has a rich background in editorial work as an Associate Editor for the American Journal of Cancer Therapy and Pharmacology, and prior research experience includes a Postdoctoral Research Fellowship at M D Anderson Cancer Center, with notable projects at the National University of Singapore and a founder role at Caveat Pte Ltd. Dev holds a Ph.D. in Bioengineering from the National University of Singapore, a Master's in Biomedical Engineering from the Indian Institute of Technology, Kharagpur, and an MBBS from Medical College, Calcutta.